약학회지

ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
Table. 2.

lncRNA/microRNA-based prognostic risk models related with immune status, tumor mutational burden, and drug sensitivity

ncRNA signature of risk model Immune status Tumor mutational burden Drug sensitivity Ref
m6A RNA methylation 1
m5C RNA methylation 9
m6A/m5C/m1A RNA methylation 10
PANoptosis 11
Cuproptosis 12
EMT 13
Oxidative stress 14
Immune 15
Genomic instability 16
Yakhak Hoeji 2024;68:152-8 https://doi.org/10.17480/psk.2024.68.3.152
© 2024 Yakhak Hoeji